Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells
Author:
Funder
National Research Foundation of Korea
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference35 articles.
1. Targeted disruption of the JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem cells leading to a reduced tumor burden;Abubaker;Front. Oncol,2014
2. The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells;Vitale;Biotechnol. Adv,2012
3. The STATs of cancer – new molecular targets come of age;Yu;Nat. Rev. Cancer,2004
4. Trichosanthes kirilowii ethanol extract and cucurbitacin D inhibit cell growth and induce apoptosis through inhibition of STAT3 activity in breast cancer cells;Kim;Evid. Based Complement. Alternat. Med,2013
5. Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer;Walker;Mol. Cell. Endocrinol,2014
Cited by 108 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Alantolactone Induced Apoptosis and DNA Damage of Cervical Cancer through ATM/CHK2 Signaling Pathway;Biological and Pharmaceutical Bulletin;2024-07-06
2. Recent advances in lycopene and germacrene a biosynthesis and their role as antineoplastic drugs;World Journal of Microbiology and Biotechnology;2024-06-25
3. Exploration of novel isoxazole-fused quinone derivatives as anti-colorectal cancer agents through inhibiting STAT3 and elevating ROS level;European Journal of Medicinal Chemistry;2024-06
4. Enhancing cancer therapy: The role of drug delivery systems in STAT3 inhibitor efficacy and safety;Life Sciences;2024-06
5. Alantolactone enhances the sensitivity of melanoma to MAPK pathway inhibitors by targeting inhibition of STAT3 activation and down-regulating stem cell markers;Cancer Cell International;2024-05-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3